Harnessing chitosan and poly-(γ-glutamic acid)-based biomaterials towards cancer immunotherapy
Cancer-related immunosuppression is one of the most challenging aspects of cancer therapy, being one of the principal causes of disease relapse. Most recent immunotherapeutic strategies have been at the forefront of therapies to overcome this problem through targeting T cell-related pathways. Notwit...
Main Authors: | Beatriz V. Lima, Maria J. Oliveira, Mário A. Barbosa, Raquel M. Gonçalves, Flávia Castro |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Elsevier
2022-08-01
|
丛编: | Materials Today Advances |
主题: | |
在线阅读: | http://www.sciencedirect.com/science/article/pii/S2590049822000480 |
相似书籍
-
Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy
由: Neelam Thakur, et al.
出版: (2020-12-01) -
Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics
由: Amreen Khan, et al.
出版: (2021-01-01) -
Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
由: Yiming Xu, et al.
出版: (2023-07-01) -
Terapia adjuvantă cu imunomodulatori în oncologie
由: Ioana Chiţescu, et al.
出版: (2023-12-01) -
Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy
由: Jin-Kyu Rhee, et al.
出版: (2014-12-01)